Erik Hedrick

1.3k total citations
24 papers, 1.0k citations indexed

About

Erik Hedrick is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Erik Hedrick has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 10 papers in Immunology. Recurrent topics in Erik Hedrick's work include Nuclear Receptors and Signaling (12 papers), Macrophage Migration Inhibitory Factor (9 papers) and Circular RNAs in diseases (6 papers). Erik Hedrick is often cited by papers focused on Nuclear Receptors and Signaling (12 papers), Macrophage Migration Inhibitory Factor (9 papers) and Circular RNAs in diseases (6 papers). Erik Hedrick collaborates with scholars based in United States, South Korea and Germany. Erik Hedrick's co-authors include Stephen Safe, Syng‐Ook Lee, Un-Ho Jin, Maen Abdelrahim, Yating Cheng, Mandip Singh, Ravi Doddapaneni, Keshav Karki, Ravi Kasiappan and James L. Abbruzzese and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Erik Hedrick

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Hedrick United States 19 648 377 284 177 152 24 1.0k
Yoonha Hwang United States 17 945 1.5× 544 1.4× 220 0.8× 286 1.6× 334 2.2× 31 1.5k
Jacob Goodwin Australia 21 564 0.9× 157 0.4× 137 0.5× 226 1.3× 101 0.7× 30 1.2k
Sébastien Sauvage Belgium 15 1.0k 1.6× 88 0.2× 166 0.6× 118 0.7× 171 1.1× 20 1.5k
Yong Jae Shin South Korea 19 598 0.9× 99 0.3× 171 0.6× 202 1.1× 218 1.4× 31 1.1k
Shengyu Yang United States 13 714 1.1× 196 0.5× 120 0.4× 120 0.7× 196 1.3× 18 1.2k
Justine Rudner Germany 21 895 1.4× 80 0.2× 133 0.5× 229 1.3× 266 1.8× 30 1.2k
Damien Duveau United States 15 753 1.2× 77 0.2× 353 1.2× 127 0.7× 137 0.9× 23 1.2k
Hong Zheng China 19 621 1.0× 59 0.2× 233 0.8× 159 0.9× 245 1.6× 47 1.1k
Richard Bond United States 15 681 1.1× 130 0.3× 220 0.8× 46 0.3× 452 3.0× 20 1.2k
Thibauld Oullier France 12 510 0.8× 115 0.3× 62 0.2× 109 0.6× 145 1.0× 27 819

Countries citing papers authored by Erik Hedrick

Since Specialization
Citations

This map shows the geographic impact of Erik Hedrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Hedrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Hedrick more than expected).

Fields of papers citing papers by Erik Hedrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Hedrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Hedrick. The network helps show where Erik Hedrick may publish in the future.

Co-authorship network of co-authors of Erik Hedrick

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Hedrick. A scholar is included among the top collaborators of Erik Hedrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Hedrick. Erik Hedrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safe, Stephen, et al.. (2021). Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer. World Journal of Gastroenterology. 27(38). 6387–6398. 8 indexed citations
2.
Hedrick, Erik, et al.. (2019). Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma. Molecular Cancer Research. 17(11). 2221–2232. 20 indexed citations
3.
Hedrick, Erik, et al.. (2019). Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists. Breast Cancer Research and Treatment. 177(1). 29–40. 26 indexed citations
4.
Hedrick, Erik, et al.. (2018). Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma. Molecular Cancer Therapeutics. 17(12). 2756–2766. 13 indexed citations
5.
Hedrick, Erik, Kumaravel Mohankumar, & Stephen Safe. (2018). TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent. Molecular Cancer Research. 16(12). 1991–2002. 26 indexed citations
6.
Cheng, Yating, Parisa Imanirad, Indira Jutooru, et al.. (2018). Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer. PLoS ONE. 13(2). e0192264–e0192264. 39 indexed citations
7.
Safe, Stephen, James L. Abbruzzese, Maen Abdelrahim, & Erik Hedrick. (2018). Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development. Cancer Prevention Research. 11(7). 371–382. 86 indexed citations
8.
Karki, Keshav, et al.. (2017). Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors. Cancer Prevention Research. 10(8). 467–477. 68 indexed citations
9.
10.
Hedrick, Erik, Xi Li, & Stephen Safe. (2016). Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors. Molecular Cancer Therapeutics. 16(1). 205–216. 56 indexed citations
11.
Hedrick, Erik, Yating Cheng, Un-Ho Jin, Kyounghyun Kim, & Stephen Safe. (2016). Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells. Oncotarget. 7(16). 22245–22256. 83 indexed citations
12.
Hedrick, Erik, Xi Li, Ketan Patel, et al.. (2016). Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS). Oncotarget. 7(21). 31257–31269. 25 indexed citations
13.
Kasiappan, Ravi, Indira Jutooru, Keshav Karki, Erik Hedrick, & Stephen Safe. (2016). Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer. Journal of Biological Chemistry. 291(53). 27122–27133. 45 indexed citations
14.
Hedrick, Erik, Syng‐Ook Lee, Ravi Doddapaneni, Mandip Singh, & Stephen Safe. (2016). NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration. Molecular and Cellular Biology. 36(9). 1383–1394. 57 indexed citations
15.
Hedrick, Erik, Lisa E.S. Crose, Corinne M. Linardic, & Stephen Safe. (2015). Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species–Dependent Targeting of Specificity Protein Transcription Factors. Molecular Cancer Therapeutics. 14(9). 2143–2153. 49 indexed citations
16.
Hedrick, Erik, Syng‐Ook Lee, Ravi Doddapaneni, Mandip Singh, & Stephen Safe. (2015). Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy. Endocrine Related Cancer. 22(5). 831–840. 49 indexed citations
17.
Hedrick, Erik, Syng‐Ook Lee, Maen Abdelrahim, et al.. (2015). Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma. PLoS ONE. 10(6). e0128308–e0128308. 54 indexed citations
18.
Lee, Syng‐Ook, Xi Li, Erik Hedrick, et al.. (2014). Diindolylmethane Analogs Bind NR4A1 and Are NR4A1 Antagonists in Colon Cancer Cells. Molecular Endocrinology. 28(10). 1729–1739. 81 indexed citations
19.
Hedrick, Erik, et al.. (2013). Differential PKA activation and AKAP association determines cell fate in cancer cells. PubMed. 8(1). 10–10. 16 indexed citations
20.
Pearson, John W., Erik Hedrick, William E. Fogler, et al.. (1990). Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.. PubMed. 50(19). 6379–88. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoonha Hwang Breakdown of academic impact, for papers by Jacob Goodwin Breakdown of academic impact, for papers by Sébastien Sauvage Breakdown of academic impact, for papers by Yong Jae Shin Breakdown of academic impact, for papers by Shengyu Yang Breakdown of academic impact, for papers by Justine Rudner Breakdown of academic impact, for papers by Damien Duveau Breakdown of academic impact, for papers by Hong Zheng Breakdown of academic impact, for papers by Richard Bond Breakdown of academic impact, for papers by Thibauld Oullier
Rankless by CCL
2026